Featured

  With over 2 million new cases annually, stroke is associated with the highest disability-adjusted life-years lost of any disease in China. The burden is expected to increase further as a [...]

Intensive intravenous glucose control did not improve functional outcome compared with standard insulin control in patients with stroke who have hyperglycaemia— and it may even increase the risk [...]

Intensive blood pressure lowering in patients treated with alteplase for acute ischaemic stroke did not lead to a significant improvement in outcome compared with guideline based blood pressure [...]

Systolic blood pressure of more than 185 mm Hg is a contraindication to thrombolytic treatment with intravenous alteplase in patients with acute ischaemic stroke, but the target systolic blood [...]

Yongjun Wang and colleagues discuss recent evidence for using dual antiplatelet therapy to reduce recurrence of stroke or transient ischaemic attack In summary, DAPT should be started as soon as [...]

Infection during delivery linked to greater risk of stroke after delivery According to preliminary research to be presented at ISC 2019, women diagnosed with an infection during delivery had a [...]

The objective of this analysis which is published in the BMJ on 24/1/2019 (2019; 364) is to investigate whether further centralisation of acute stroke services in Greater Manchester in 2015 was [...]

Dr. Amer Jafar, Fellow of the Royal College of Physicians, London is talking on 7th February 2019 at 7pm about Stroke in Wales. The venue is the Post Graduate Centre in Royal Glamorgan Hospital, [...]

Michael G Hennerici writes: Today, aware of the increasing number of meetings, and faced with expectations of commercial sponsorship both for free participation, and the added risks of dilution [...]

  A substantial proportion of patients with ischaemic stroke present with embolic stroke of undetermined source (ESUS), which is associated with a considerable rate of recurrence. The [...]